Data
Lookout
Search
Browse
Diseases
Sponsors
Pipeline Pulse
Weekly Report
Watchlist
Blog
Pricing
Sign In
Home
NCT07560709
Clinical Trial
Single-Patient Expanded Access Protocol - RNA-LP in a Patient With Recurrent Osteosarcoma
No Longer Available
View on ClinicalTrials.gov →
Summary
Treatment of a patient with recurrent osteosarcoma with personalized pp65/tumor mRNA RNA-LP under an individual patient expanded access protocol.
Trial Details
NCT Number
NCT07560709
Lead Sponsor
University of Florida
Conditions
Recurrent Osteosarcoma
Updated on ClinicalTrials.gov
2026-05-01